<img alt="" height="1" width="1" />Investors pump up Salix sharesNews & ObserverLater this year, Salix intends to apply for regulatory approval to promote Xifaxan as a treatment for irritable bowel syndrome. The company projects that ...US panel backs Salix antibiotic for liver disorder<nobr>Reuters</nobr>Salix Pulls Off Surprise Win<nobr>Minyanville.com</nobr>FDA panel boosts Salix<nobr>News & Observer</nobr><nobr>News & Observer</nobr><nobr>all 183 news articles »</nobr> |